Genpharmasec Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 329838,
    "name": "Genpharmasec",
    "stock_name": "Genpharmasec",
    "full_name": "Genpharmasec Ltd",
    "name_url": "stocks-analysis/genpharmasec",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1.30",
    "chg": 0.06,
    "chgp": "4.84%",
    "dir": 1,
    "prev_price": "1.24",
    "mcapval": "70.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531592,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "sector_id": 79,
    "indexname": "India SENSEX",
    "isin": "INE861N01036",
    "curr_date": "Sep 03, 01:11 PM",
    "curr_time": "13:15 PM",
    "last_traded_at": "Sep 03, 01:11 PM IST",
    "bse_nse_vol": "9.42 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 03, 2026",
    "traded_date_str": "2026 09 03",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/genpharmasec-329838-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4161101",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GenpharmasecLtd_mojoScore_4161101.png",
        "date": "2026-08-19 10:10:33",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Genpharmasec Ltd Reports Positive Quarterly Growth Amidst Lingering Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpharmasec-ltd-reports-positive-quarterly-growth-amidst-lingering-market-challenges-4148966",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GenpharmasecLtd_fintrenddot_4148966.png",
        "date": "2026-08-12 08:00:14",
        "description": "Genpharmasec Ltd has delivered a notably positive financial performance in the quarter ended June 2026, with net sales surging 42.1% compared to the previous four-quarter average and a higher PAT of ₹1.75 crores over the last six months. Despite this encouraging quarterly momentum, the company continues to face significant headwinds reflected in its long-term returns and a recent downgrade to a Strong Sell rating by MarketsMOJO."
      },
      {
        "title": "When is the next results date for Genpharmasec Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-genpharmasec-ltd-4136298",
        "imagepath": "",
        "date": "2026-08-04 23:18:10",
        "description": "The next results date for Genpharmasec Ltd is scheduled for 11 August 2026...."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4135068",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/GenpharmasecLtd_mojoScore_4135068.png",
        "date": "2026-08-04 10:10:22",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4112493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GenpharmasecLtd_mojoScore_4112493.png",
        "date": "2026-07-21 10:10:04",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 21 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4096387",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/GenpharmasecLtd_mojoScore_4096387.png",
        "date": "2026-07-10 10:10:04",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 10 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4076970",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GenpharmasecLtd_mojoScore_4076970.png",
        "date": "2026-06-29 10:10:05",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Genpharmasec Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/genpharmasec-ltd-is-rated-strong-sell-4058908",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GenpharmasecLtd_mojoScore_4058908.png",
        "date": "2026-06-17 10:10:03",
        "description": "Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 5440,
    "sid": "329838",
    "stock_news_url": "https://www.marketsmojo.com/news/genpharmasec-329838"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "31-Aug-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Rajesh Sadhwani",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday 02Nd September 2026.",
      "datetime": "28-Aug-2026",
      "details": "Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 inter alia to consider and approve 1. To Fix the Day Date Time and Mode of 34th Annual General Meeting of the Company for the year ended March 31 2026 and approve Draft notice and Calendar of Events for the same. 2. To Fix the Cut- off date to determine the entitlement of voting rights of members for E-voting and to fix the commencement and closing date for E-voting. 3. To consider and approve the Directors Report for the year ended March 31 2026. 4. To consider and approve Annual Report for Financial Year 2025-26. 5. To approve closure of Share Transfer Books & Register of Members for the 34th Annual General Meeting. 6. To Consider and approve the appointment of Scrutinizer for E-voting at the ensuing 34th Annual General Meeting. 7. Any other Matter with the permission of the Chairman.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "13-Aug-2026",
      "details": "Regarding Recent Agreement with Amneal Healthcare Private Limited",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Apr 19",
          "dt": "2019-04-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Genpharmasec Ltd has announced <strong>1:1</strong> rights issue, ex-date: 09 Jan 24",
          "dt": "2024-01-09",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Genpharmasec Ltd is Rated Strong Sell

2026-08-19 10:10:33

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 19 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Genpharmasec Ltd Reports Positive Quarterly Growth Amidst Lingering Market Challenges

2026-08-12 08:00:14

Genpharmasec Ltd has delivered a notably positive financial performance in the quarter ended June 2026, with net sales surging 42.1% compared to the previous four-quarter average and a higher PAT of ₹1.75 crores over the last six months. Despite this encouraging quarterly momentum, the company continues to face significant headwinds reflected in its long-term returns and a recent downgrade to a Strong Sell rating by MarketsMOJO.

Read full news article

When is the next results date for Genpharmasec Ltd?

2026-08-04 23:18:10

The next results date for Genpharmasec Ltd is scheduled for 11 August 2026....

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-08-04 10:10:22

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-07-21 10:10:04

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 21 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-07-10 10:10:04

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 10 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-06-29 10:10:05

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Genpharmasec Ltd is Rated Strong Sell

2026-06-17 10:10:03

Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News

Announcement

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

31-Aug-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Rajesh Sadhwani

Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday 02Nd September 2026.

28-Aug-2026 | Source : BSE

Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 inter alia to consider and approve 1. To Fix the Day Date Time and Mode of 34th Annual General Meeting of the Company for the year ended March 31 2026 and approve Draft notice and Calendar of Events for the same. 2. To Fix the Cut- off date to determine the entitlement of voting rights of members for E-voting and to fix the commencement and closing date for E-voting. 3. To consider and approve the Directors Report for the year ended March 31 2026. 4. To consider and approve Annual Report for Financial Year 2025-26. 5. To approve closure of Share Transfer Books & Register of Members for the 34th Annual General Meeting. 6. To Consider and approve the appointment of Scrutinizer for E-voting at the ensuing 34th Annual General Meeting. 7. Any other Matter with the permission of the Chairman.